These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1645153)

  • 1. Haemagglutination by parvovirus B19.
    Brown KE; Cohen BJ
    J Gen Virol; 1992 Aug; 73 ( Pt 8)():2147-9. PubMed ID: 1645153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application to immunoglobulin M capture hemadherence assays of hemagglutination of monkey erythrocytes by native and recombinant human parvovirus B19 antigens.
    Cubel RC; Alferes AC; Cohen BJ; Nascimento JP
    J Clin Microbiol; 1994 Aug; 32(8):1997-9. PubMed ID: 7989556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
    Pfrepper KI; Enders M; Motz M
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):362-5. PubMed ID: 16316402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosing human parvovirus B19 infection: guidelines for test selection.
    Jordan JA
    Mol Diagn; 2001 Dec; 6(4):307-12. PubMed ID: 11774195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphology and antigenicity of recombinant B19 parvovirus capsids expressed in transfected COS-7 cells.
    Cohen BJ; Field AM; Mori J; Brown KE; Clewley JP; St Amand J; Astell CR
    J Gen Virol; 1995 May; 76 ( Pt 5)():1233-7. PubMed ID: 7730807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen.
    Heegaard ED; Rasksen CJ; Christensen J
    J Med Virol; 2002 Jul; 67(3):375-83. PubMed ID: 12116031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.
    Ekman A; Hokynar K; Kakkola L; Kantola K; Hedman L; Bondén H; Gessner M; Aberham C; Norja P; Miettinen S; Hedman K; Söderlund-Venermo M
    J Virol; 2007 Jul; 81(13):6927-35. PubMed ID: 17409158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen).
    Brown KE; Hibbs JR; Gallinella G; Anderson SM; Lehman ED; McCarthy P; Young NS
    N Engl J Med; 1994 Apr; 330(17):1192-6. PubMed ID: 8139629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of blood donors for human parvovirus B19 and characterization of the results.
    Wakamatsu C; Takakura F; Kojima E; Kiriyama Y; Goto N; Matsumoto K; Oyama M; Sato H; Okochi K; Maeda Y
    Vox Sang; 1999; 76(1):14-21. PubMed ID: 9933849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin.
    Cassinotti P; Siegl G; Michel BA; Brühlmann P
    J Med Virol; 1998 Nov; 56(3):199-204. PubMed ID: 9783685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of parvovirus B19 infection in hematological patients with partial red cell aplasia of the bone marrow].
    Iaguzhinskaia OE; Pivnik AV; Fevraleva IS; Sudarikov AB; Lisovina IuS; Loginova IV; Shitareva IV
    Ter Arkh; 2001; 73(8):50-6. PubMed ID: 11599268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of parvovirus B19 IgM antibodies and DNA in pure red cell aplasia resulting in myelodysplasia--a case report.
    Kishore J; Mukhopadhyay C
    Indian J Pathol Microbiol; 2004 Jan; 47(1):78-81. PubMed ID: 15471143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of IgG antibodies to human parvovirus B19 in haemophilia children treated with recombinant factor (F)VIII only or with at least one plasma-derived FVIII or FIX concentrate: results from the French haemophilia cohort.
    Gaboulaud V; Parquet A; Tahiri C; Claeyssens S; Potard V; Faradji A; Peynet J; Costagliola D;
    Br J Haematol; 2002 Feb; 116(2):383-9. PubMed ID: 11841442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo State, Nigeria.
    Abiodun I; Opaleye OO; Ojurongbe O; Fagbami AH
    J Infect Dev Ctries; 2013 Dec; 7(12):946-50. PubMed ID: 24334941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human parvovirus B19 in patients with aplastic anemia.
    Mishra B; Malhotra P; Ratho RK; Singh MP; Varma S; Varma N
    Am J Hematol; 2005 Jun; 79(2):166-7. PubMed ID: 15929106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
    Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
    J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte P antigen: cellular receptor for B19 parvovirus.
    Brown KE; Anderson SM; Young NS
    Science; 1993 Oct; 262(5130):114-7. PubMed ID: 8211117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro erythroid effects of human stem cell factor in a case of human immunodeficiency virus-related chronic parvovirus B19 induced anemia.
    Liesveld JL; Weissbach NE; Shafer JA; Abboud CN
    Hematol Pathol; 1993; 7(1):23-32. PubMed ID: 7682213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital].
    Regaya F; Khelifa R; Zouari R; Kchir M; Karoui M; Essid R
    Arch Inst Pasteur Tunis; 2003; 80(1-4):9-15. PubMed ID: 15941063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
    Cassinotti P; Burtonboy G; Fopp M; Siegl G
    J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.